← SynDRA
TIPIRACIL
SynDRA canonical compound SYN0007626 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | TYMP |
| Mechanism of action | Thymidine phosphorylase inhibitor |
| Indication | colorectal cancer |
| Disease area | oncology |
All known targets
Mechanisms of action (all sources)
- Thymidine phosphorylase inhibitor
- TYMP INHIBITOR
Drug classes
- Thymidine Phosphorylase Inhibitors
- Thymidine Phosphorylase Inhibitor
Cross-references
Synonyms
- tipiracil hydrochloride
- tipiracil HCl
- Tipiracilo
- MA-1
- TPI (freebase)
- 5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]-1H-pyrimidine-2,4-dione
- NGO10K751P
- 5-CHLORO-6-(1-(2-IMINOPYRROLIDINYL) METHYL) URACIL
- 5-CHLORO-6-[(2-IMINOPYRROLIDIN-1-YL)METHYL]PYRIMIDINE-2,4(1H,3H)-DIONE
- TPI
- 5-Chloro-6-((2-iminopyrrolidin-1-yl)methyl)pyrimidine-2,4(1H,3H)-dione
- 5-Chloro-6-((2-iminopyrrolidin-1-yl)methyl)pyrimidine-2,4-(1H,3H)-dione
- 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1h,3h)-pyrimidinedione
- 5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
- Tipiracil [INN]
- Tipiracil [USAN:INN]
- 5-CIMU
- UNII-NGO10K751P
- 5-Chloro-6-[(2-iminopyrrolidin-1-yl)methyl]pyrimidine-2,4-(1H,3H)-dione
- TIPIRACIL [MI]
- TIPIRACIL [USAN]
- TIPIRACIL [WHO-DD]
- CHEMBL235668
- GTPL8696
- SCHEMBL1682960
- BDBM20079
- CHEBI:90879
- HY-A0063A
- DTXSID601025833
- HMS3745A05
- BCP24231
- BDBM50531739
- ZINC100032379
- CS-5895
- DB02631
- DB09343
- NCGC00389632-02
- NCGC00389632-07
Reported adverse events
- Abdominal pain
- Alopecia
- Constipation
- Dysgeusia
- Fatigue
- Headache
- Hypertension
- Infection
- Nausea
- Neutropenia
- Proteinuria
- Pyrexia
Look up TIPIRACIL in the interactive SynDRA portal →